South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report

Rakesh Kumar, Narendra Arora, Mathuram Santosham

Research output: Contribution to journalArticlepeer-review


Despite the licensure of the pneumococcal conjugate vaccine (PCV) in the US and other Western countries for over 14 years, as of September 2014 only 4 South Asian countries were using PCV in their universal immunization program. To generate momentum toward addressing this issue a "South Asia symposium on pneumococcal disease and the promise of vaccines" was organized just prior to the 9th international symposium on pneumococci and pneumococcal diseases held in India recently. Leading scientists, program managers, and decision makers including ministry officials from the region participated in the meeting. The participants discussed available data on pneumococcal disease burden in South Asia, surveillance methods, efficacy and safety of pneumococcal conjugate vaccines (PCV), the status of PCV introduction, programmatic challenges in introducing PCV and available data on the impact of PCV in South Asia and globally. There was a strong consensus that available data on disease burden and the global experience with PCV justified the introduction PCV in all Asian countries in order to accelerate the gains in child survival in the region.

Original languageEnglish (US)
Pages (from-to)2622-2626
Number of pages5
Issue number23
StatePublished - May 17 2016


  • Immunization programs
  • India
  • Pneumococcal conjugate vaccines
  • Pneumococcal disease burden
  • South Asia
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report'. Together they form a unique fingerprint.

Cite this